Pleural mesothelioma is divided into four stages, each detailing how far the tumor has spread. The different stages help doctors determine the best course of treatment.
Answers to these questions lead to treatment options and to a potential prognosis. The earlier that the cancer is caught, the more likely the patient will receive a prognosis of increased life span. Different treatment options are also more viable during these early stages.
To determine the stage of someone's mesothelioma, doctors can schedule a variety of diagnostic tests. These may include biopsies, blood tests or imaging scans like X-rays, CT scans or PET scans. Results from these tests reveal crucial information about the cancer that helps doctors select the best treatments and determine the patient's survival outlook. They can also assist doctors with finding relevant clinical trials that may benefit the patient.
For most cancers, including pleural mesothelioma, doctors assign a stage in the form of a Roman numeral. The Roman numerals range from I to IV, with more advanced cancers having a higher stage number. To translate the results of diagnostic tests into an accurate stage, doctors use what is called the TNM staging system.
Developed in the early 1940s, the TNM system has been specialized for many types of cancer over the years. It continues to evolve as scientists learn more about how cancer grows and spreads throughout the body.
In 1995, the International Mesothelioma Interest Group (IMIG) developed a formal staging system for pleural mesothelioma based off of the TNM system. This uniform system is used internationally to give doctors a common way to describe the disease, which is crucial for guiding clinical trials and treatment of the disease.
The TNM Staging System centers on three factors that describe key aspects of the patient's cancer:
|T||Stands for tumor and describes the size of the primary tumor and the extent of its spread.|
|N||Stands for node and evaluates the extent of cancer spread to nearby lymph nodes, which are small, oval-shaped organs of the immune system where cancer typically spreads first.|
|M||Stands for metastasis and indicates whether the cancer has metastasized, or spread, to distant organs or lymph nodes.|
Once a doctor evaluates the patient's cancer for TNM characteristics, a number or letter is added to each letter to further describe the progression of cancer. The numbers begin at zero and increase as the cancer advances. If any factor can't be assessed for some reason, an X is used.
For pleural mesothelioma, the meaning behind the letters and numbers attached to each factor is as follows:
For the T group, numbers following the T increase based on the size of the primary tumor and how much it has grown into nearby tissues.
|TX||The main tumor cannot be assessed.|
|T0||There is no evidence of a primary tumor.|
|T1a||The mesothelioma tumor involves the lining of the chest wall (parietal pleura) on one side of the chest, but not the lining of the lung surface (visceral pleura). It may also affect the pleural lining of the breathing muscle (diaphragm) or the space between the lungs (mediastinum).|
|T1b||The tumor involves both the parietal and visceral pleura on one side of the chest. It may also affect the diaphragm or mediastinum.|
|T2||The tumor involves the pleural lining of the chest wall on one side of the chest, as well as the pleural lining of the diaphragm, mediastinum and the lung. The cancer has also grown into at least one of the following:
|T3||The mesothelioma is considered locally advanced, but may still be able to be removed surgically. The tumor involves the pleura lining the chest wall and the pleura lining the lung, diaphragm and mediastinum on one side of the chest. It has also grown into at least one of the following:
|T4||The mesothelioma is considered technically unresectable, meaning it cannot be completely removed surgically. The tumor involves the pleura lining the chest wall and the pleura lining the lung, diaphragm and mediastinum on one side of the chest. It has also grown into at least one of the following:
For the N group, numbers following the N describe the location, size and number of lymph nodes affected by the cancer. The more cancerous lymph nodes there are, the higher the N number.
|NX||Nearby lymph nodes cannot be assessed.|
|N0||There is no spread to nearby lymph nodes.|
|N1||Cancer has spread to lymph nodes in the lung and/or the hilar lymph nodes, located near the area where the bronchus enters the lung. Only lymph nodes on the same side of the chest as the main tumor are affected.|
|N2||Cancer has spread to other lymph nodes on the same side of the chest as the main tumor, such as subcarinal lymph nodes and mediastinal lymph nodes. N2 also includes spread to lymph nodes behind the breastbone and near the diaphragm.|
|N3||Cancer has spread to supraclavicular lymph nodes near the collarbone on either side and/or hilar lymph nodes on the side of the chest opposite the main tumor.|
For the M group, only two numbers are used to describe the extent of the cancer's spread throughout the body.
|M0||There is no spread to distant parts of the body.|
|M1||Cancer has spread to distant organs or lymph nodes.|
Once cancer doctors assign values to the T, N and M categories with data from diagnostic tests or surgical techniques, they combine the values into a string of letters and numbers that give an accurate depiction of the extent of cancer at diagnosis.
T1aN0M0, for example, indicates there is a mesothelioma tumor on the pleural lining of the chest wall with no lymph node involvement and no sign of spread to distant organs. With this information, doctors can then assign a Roman numeral stage that plays an important role in pleural mesothelioma treatment and research.
Using the previous example of T1aN0M0, doctors would refer to this diagnosis as a Stage IA tumor. While the mesothelioma may progress further, the stage at diagnosis stays the same throughout treatment.
The table below lists each Roman numeral stage for pleural mesothelioma and the corresponding TNM values.
N0, N1, N2
Sponsored by The Peterson Firm, 1050 30th Street NW, Washington, DC 20007 © 2018 PleuralMesothelioma.com